1-7 of 7
Samuel Yamshon
Close
Sort by
Journal Articles

Low Dose Total Body Irradiation Improves CD19 CAR-T Expansion, Persistence, and Trafficking, Leading to Enhanced Efficacy in Large B-Cell Lymphoma

Mohammad Alhomoud, Michelle Foley, Mayumi Sugita, Takahiro Yamazaki, Leandro Martinez, Samuel Yamshon, Alexandra Gomez-Arteaga, Paul Pagnini, Tsiporah B. Shore, Olivier Boyer, Renier Brentjens, Koen Van Besien, Lorenzo Galluzzi, Silvia Formenti, Jeremie Martinet, Monica L. Guzman
Journal: Blood
Blood (2023) 142 (Supplement 1): 1016.
https://doi.org/10.1182/blood-2023-185216
Published: 2023
Journal Articles

Axicabtagene Ciloleucel in Patients Aged 75 and Older: A Retrospective Cohort Study

Neela Easwar, Joshua Fein, Michelle S Pasciolla, Rachel Abramova, Tsiporah B. Shore, Samuel Yamshon
Journal: Blood
Blood (2023) 142 (Supplement 1): 6318.
https://doi.org/10.1182/blood-2023-178187
Published: 2023
Journal Articles

Analysis of Outcomes and Predictors of Response in Patients with Relapsed Mantle Cell Lymphoma Treated with Brexucabtagene Autoleucel

Jason T. Romancik, Subir Goyal, James N Gerson, Hatcher J Ballard, Yazeed Sawalha, David A. Bond, Michael Joseph Rogalski, Irl Brian Greenwell, Koen van Besien, Samuel Yamshon, Reem Karmali, Imran Nizamuddin, Pallawi Torka, Victor A. Chow, Mazyar Shadman, Nilanjan Ghosh, Tamara K. Moyo, Timothy S. Fenske, Alexandra Rezazadeh, Natalie S Grover, Kami J. Maddocks, Caron Jacobson, Jonathon B. Cohen
Journal: Blood
Blood (2021) 138 (Supplement 1): 1756.
https://doi.org/10.1182/blood-2021-153277
Published: 2021
Journal Articles

Initial Treatment with Lenalidomide Plus Rituximab for Mantle Cell Lymphoma (MCL): 7-Year Analysis from a Multi-Center Phase II Study

Samuel Yamshon, MD, Peter Martin, FRCPC, MD MS, Bijal Shah, MD, Stephen J. Schuster, MD, Paul J Christos, Dr.P.H., M.S., Amelyn Rodriguez, BSN, RN, OCN, Sonali M. Smith, MD, Jakub Svoboda, MD, Richard R. Furman, MD, Sarah C. Rutherford, MD, John N. Allan, MD, John P. Leonard, MD, Jia Ruan, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-138731
Published: 2020
Journal Articles

Non-Destructive Post-Transplant Lymphoproliferative Disorder Shows Distinct Clinical Features with HHV-6 Reactivation in a Subset

Samuel Yamshon, MD, Miguel Dario Cantu, Ethel Cesarman, MD PhD, Sarah C. Rutherford, MD, Amy Chadburn, MD, Genevieve Marie Crane, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2792.
https://doi.org/10.1182/blood-2019-128374
Published: 2019
Journal Articles

Venous Thromboembolism in Patients with B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Lenalidomide

Samuel Yamshon, MD, Michelle Demetres, BA, Hoda Hammad, MS, MPH, Paul J Christos, Dr.P.H., M.S., John P. Leonard, MD, Jia Ruan, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 221.
https://doi.org/10.1182/blood.V130.Suppl_1.221.677
Published: 2017
Journal Articles

Correlative Analysis and Clinical Update Of a Phase II Study Using Lenalidomide and Rituximab In Patients With Indolent Non-Hodgkin Lymphoma

Samuel Yamshon, Lihong Qi, PhD, Chaoyu Yu, Xiao-Dong Li, PhD, Robert O'Donnell, MD, PhD, Joseph Tuscano, MD
Journal: Blood
Blood (2013) 122 (21): 249.
https://doi.org/10.1182/blood.V122.21.249.249
Published: 2013